FDA grants priority review status to Alza' sNDA for Doxil in ovarian cancer April 20, 1999 No Comments
European Commission approves novel albumin-free treatment for hemophilia A April 19, 1999 No Comments
FDA approves amprenavir, first new protease inhibitor in more than two years April 19, 1999 No Comments
In vitro and in vivo antitumor effects of noscapine discussed at AACR meeting April 15, 1999 No Comments
RSS